# Post-surgical Outcomes With Anabolic Agent Use in High-risk Ankle Fractures: A Pilot RCT

> **NCT06303284** · PHASE1,PHASE2 · NOT_YET_RECRUITING · sponsor: **University of Calgary** · enrollment: 80 (estimated)

## Conditions studied

- Ankle Fractures

## Interventions

- **DRUG:** subcutaneous Teriparatide injection
- **OTHER:** placebo

## Key facts

- **NCT ID:** NCT06303284
- **Lead sponsor:** University of Calgary
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-01-01
- **Primary completion:** 2026-12-31
- **Final completion:** 2027-06-01
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2024-03-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06303284

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06303284, "Post-surgical Outcomes With Anabolic Agent Use in High-risk Ankle Fractures: A Pilot RCT". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06303284. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*